Patent details

Basic Information

Publication number:

EP1530965

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP030257695

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Controlled release delivery system of sexual hormones for nasal application

French Title of Invention:

Composition à liberation prolongée pour application nasale comprenant des hormones sexuelles

German Title of Invention:

Nasenformulierung mit kontrollierter Freisetzung von Sexualhormonen

SPC Number:

Dates

Filing date:

11/11/2003

Grant date:

08/03/2006

EP Publication Date:

08/03/2006

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/05/2005

EP B1 Publication Date:

08/03/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/11/2022

Expiration date:

11/11/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/01/2007

 

 

Name:

M & P Patent Aktiengesellschaft

Address:

c/o Fundationsanstalt Heiligenkreuz 6, 9490 Vaduz, Liechtenstein (LI)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

08/03/2006

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

Name:

Mattern Claudia

Address:

Switzerland (CH)

Classification

Main IPC Class:

A61K 9/107;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

25/10/2021

Last Annual Fee Paid Number:

19

Last Annual Fee Paid Amount:

281 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages